Eloxx Pharmaceuticals, Inc.
ELOX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001035354
No open-market purchases or sales by Eloxx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Eloxx Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −2 vs. Q3 2021
- Shares held
- 16.5M
- +422.3K (+2.6%) vs. Q3 2021
- Total value
- $11.7M
- −$14.4M (−55.2%) vs. Q3 2021
- New holders
- 10
- 8 more added
- Sold out
- 12
- 14 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELOX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $34.7M |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $43 |
| Q1 2024 | 1 | $62 |
| Q4 2023 | 4 | $109.0K |
| Q3 2023 | 18 | $2.50M |
| Q2 2023 | 16 | $924.2K |
| Q1 2023 | 19 | $671.5K |
| Q4 2022 | 19 | $476.7K |
| Q3 2022 | 32 | $2.14M |
| Q2 2022 | 32 | $3.51M |
| Q1 2022 | 36 | $8.42M |
| Q4 2021 | 39 | $11.7M |
| Q3 2021 | 41 | $26.0M |
| Q2 2021 | 47 | $33.2M |
| Q1 2021 | 38 | $28.7M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Eloxx Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 41 | $0 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 6 | $0 | 0.00% | +6 | New |
| BNP Paribas Arbitrage, SA | 647 | $457 | 0.00% | −75−10.4% | Reduced |
| Morgan Stanley | 3,691 | $2.00K | 0.00% | +2,898+365.4% | Added |
| Tower Research Capital LLC (TRC) | 9,596 | $7.00K | 0.00% | +9,596 | New |
| Victory Capital Management Inc | 10,791 | $8.00K | 0.00% | −329−3.0% | Reduced |
| Advisor Group Holdings, Inc. | 12,359 | $9.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 17,223 | $12.0K | 0.00% | +11,146+183.4% | Added |
| Two Sigma Securities, LLC | 17,499 | $12.0K | 0.00% | +17,499 | New |
| D. E. Shaw & Co., Inc. | 21,295 | $15.0K | 0.00% | −42,403−66.6% | Reduced |
| Citadel Advisors LLC | 22,350 | $16.0K | 0.00% | −81,938−78.6% | Reduced |
| Rafferty Asset Management, LLC | 26,072 | $18.0K | 0.00% | +26,072 | New |
| Occudo Quantitative Strategies LP | 29,492 | $21.0K | 0.00% | −12,150−29.2% | Reduced |
| Susquehanna International Group, LLP | 34,652 | $25.0K | 0.00% | −10,392−23.1% | Reduced |
| Simplex Trading, LLC | 43,198 | $30.0K | 0.00% | −52,504−54.9% | Reduced |
| Group One Trading, L.P. | 44,772 | $31.0K | 0.00% | +44,772 | New |
| Wells Fargo & Company | 46,670 | $33.0K | 0.00% | +25,300+118.4% | Added |
| B. Riley Wealth Management, Inc. | 48,500 | $34.0K | 0.00% | +48,500 | New |
| Atom Investors LP | 113,151 | $80.0K | 0.02% | +113,151 | New |
| Two Sigma Investments, LP | 117,729 | $83.0K | 0.00% | −197,145−62.6% | Reduced |
| Northern Trust Corp | 124,369 | $88.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 130,270 | $91.0K | 0.01% | +130,270 | New |
| Bank of New York Mellon Corp | 146,291 | $103.0K | 0.00% | +70,169+92.2% | Added |
| Vanguard Capital Wealth Advisors | 158,900 | $111.0K | 0.08% | −279,000−63.7% | Reduced |
| Millennium Management LLC | 175,564 | $123.0K | 0.00% | −98,733−36.0% | Reduced |
| State Street Corp | 182,003 | $127.0K | 0.00% | −12,400−6.4% | Reduced |
| Bridgeway Capital Management, LLC | 309,400 | $217.0K | 0.00% | +218,000+238.5% | Added |
| Two Sigma Advisers, LP | 468,000 | $331.0K | 0.00% | −237,300−33.6% | Reduced |
| BlackRock Inc. | 508,135 | $360.0K | 0.00% | +17,264+3.5% | Added |
| Anson Funds Management LP | 553,652 | $391.0K | 0.05% | +553,652 | New |
| Clal Insurance Enterprises Holdings Ltd | 585,000 | $413.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 798,058 | $558.0K | 0.00% | +25,222+3.3% | Added |
| Nantahala Capital Management, LLC | 894,659 | $632.0K | 0.04% | −314,679−26.0% | Reduced |
| Altshuler Shaham Ltd | 1,157,540 | $828.0K | 0.02% | 00.0% | Unchanged |
| Harel Insurance Investments & Financial Services Ltd. | 1,176,401 | $831.0K | 0.02% | +1,176,401 | New |
| American Financial Group Inc | 1,480,000 | $1.04M | 0.29% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 1,930,092 | $1.36M | 0.61% | +670,252+53.2% | Added |
| Menora Mivtachim Holdings Ltd. | 2,094,208 | $1.48M | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,037,489 | $2.14M | 0.00% | −9,549−0.3% | Reduced |
| Altium Capital Management LP | 0 | $0 | 0.00% | −1,118,000−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −103,900−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −32,510−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −27,588−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −25,778−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −22,700−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −19,720−100.0% | Sold out |
| Mesirow Financial Investment Management, Inc. | 0 | $0 | 0.00% | −18,894−100.0% | Sold out |
| Sawtooth Solutions, LLC | 0 | $0 | 0.00% | −16,201−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −3,678−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −338−100.0% | Sold out |
| Brewin Dolphin Ltd | 0 | $0 | 0.00% | −15−100.0% | Sold out |